CA2328138A1 - Technique de diagnostic, de suivi et de stadification du cancer du poumon - Google Patents
Technique de diagnostic, de suivi et de stadification du cancer du poumon Download PDFInfo
- Publication number
- CA2328138A1 CA2328138A1 CA002328138A CA2328138A CA2328138A1 CA 2328138 A1 CA2328138 A1 CA 2328138A1 CA 002328138 A CA002328138 A CA 002328138A CA 2328138 A CA2328138 A CA 2328138A CA 2328138 A1 CA2328138 A1 CA 2328138A1
- Authority
- CA
- Canada
- Prior art keywords
- lsg
- levels
- cancer
- lung
- patient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
- G01N33/57407—Specifically defined cancers
- G01N33/57423—Specifically defined cancers of lung
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6876—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes
- C12Q1/6883—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material
- C12Q1/6886—Nucleic acid products used in the analysis of nucleic acids, e.g. primers or probes for diseases caused by alterations of genetic material for cancer
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/106—Pharmacogenomics, i.e. genetic variability in individual responses to drugs and drug metabolism
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2600/00—Oligonucleotides characterized by their use
- C12Q2600/112—Disease subtyping, staging or classification
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Engineering & Computer Science (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Pathology (AREA)
- Organic Chemistry (AREA)
- Analytical Chemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Physics & Mathematics (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- Oncology (AREA)
- Hospice & Palliative Care (AREA)
- Genetics & Genomics (AREA)
- Cell Biology (AREA)
- Biophysics (AREA)
- General Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Food Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
La présente invention concerne une technique permettant de faire la détection, le diagnostic, le suivi, la stadification et le progonostic du cancer du poumon.
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US8621298P | 1998-05-21 | 1998-05-21 | |
US60/086,212 | 1998-05-21 | ||
PCT/US1999/010344 WO1999060160A1 (fr) | 1998-05-21 | 1999-05-12 | Technique de diagnostic, de suivi et de stadification du cancer du poumon |
Publications (1)
Publication Number | Publication Date |
---|---|
CA2328138A1 true CA2328138A1 (fr) | 1999-11-25 |
Family
ID=22197037
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CA002328138A Abandoned CA2328138A1 (fr) | 1998-05-21 | 1999-05-12 | Technique de diagnostic, de suivi et de stadification du cancer du poumon |
Country Status (4)
Country | Link |
---|---|
EP (1) | EP1082459A4 (fr) |
JP (1) | JP3688585B2 (fr) |
CA (1) | CA2328138A1 (fr) |
WO (1) | WO1999060160A1 (fr) |
Families Citing this family (27)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030130182A1 (en) * | 1997-11-05 | 2003-07-10 | Genentech, Inc. | Secreted and transmembrane polypeptides and nucleic acids encoding the same |
US7291712B2 (en) | 1998-06-25 | 2007-11-06 | Genentech, Inc. | Interleukin-8 homologous polypeptides and therapeutic uses thereof |
CA2347656A1 (fr) * | 1998-08-04 | 2000-02-17 | Diadexus, Inc. | Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement du cancer des poumons |
EP2053129A3 (fr) * | 1998-09-02 | 2009-08-19 | Diadexus, Inc. | Procédé de diagnostic, surveillance, stratification, imagerie et traitement de divers cancers |
US20020004206A1 (en) * | 1999-04-09 | 2002-01-10 | Berger Barry M. | Methods of screening for disease |
US20030211510A1 (en) | 1999-06-30 | 2003-11-13 | Corixa Corporation | Compositions and methods for the therapy and diagnosis of lung cancer |
WO2001053349A2 (fr) | 2000-01-21 | 2001-07-26 | Ludwig Institute For Cancer Research | Antigenes associes au cancer du poumon a petites cellules et utilisations de ces antigenes |
AU2001241656A1 (en) * | 2000-02-17 | 2001-08-27 | Diadexus, Inc. | Methods for diagnosing, monitoring, staging, imaging and treating lung cancer via lung cancer specific genes |
US20020119156A1 (en) * | 2000-03-29 | 2002-08-29 | Sei-Yu Chen | Compositions and methods of diagnosing, monitoring, staging, imaging and treating lung cancer |
AU2001277937A1 (en) * | 2000-07-21 | 2002-02-05 | Diadexus, Inc. | Compositions and methods relating to lung specific genes |
JP2004520814A (ja) * | 2000-08-28 | 2004-07-15 | ディアデクサス インコーポレーテッド | 肺特異的遺伝子に関する組成物および方法 |
WO2002077236A2 (fr) * | 2000-10-26 | 2002-10-03 | Diadexus, Inc. | Compositions et procedes associes aux genes et aux proteines specifiques du poumon |
WO2002068633A2 (fr) * | 2000-11-22 | 2002-09-06 | Diadexus, Inc. | Compositions et procedes concernant des genes et proteines specifiques aux poumons |
EP1873245A1 (fr) * | 2001-02-28 | 2008-01-02 | Genentech, Inc. | Polypeptides homologue à l'interleukine-8 et utilisations thérapeutiques correspondantes |
US7332590B2 (en) | 2001-08-16 | 2008-02-19 | The United States Of America As Represented By The Department Of Health And Human Services | Molecular characteristics of non-small cell lung cancer |
DE10254601A1 (de) * | 2002-11-22 | 2004-06-03 | Ganymed Pharmaceuticals Ag | Differentiell in Tumoren exprimierte Genprodukte und deren Verwendung |
WO2006013012A2 (fr) * | 2004-08-04 | 2006-02-09 | Bayer Healthcare Ag | Diagnostics et therapeutique pour maladies liees a la napsine 1 (nap1) |
WO2006047787A2 (fr) | 2004-10-27 | 2006-05-04 | Exact Sciences Corporation | Methode de surveillance de la progression ou la recurrence d'une maladie |
WO2006113467A2 (fr) | 2005-04-14 | 2006-10-26 | The Trustees Of Boston University | Diagnostic des troubles pulmonaires mettant en oeuvre la prediction de categories |
US9777314B2 (en) | 2005-04-21 | 2017-10-03 | Esoterix Genetic Laboratories, Llc | Analysis of heterogeneous nucleic acid samples |
WO2007103541A2 (fr) | 2006-03-09 | 2007-09-13 | The Trustees Of Boston University | Méthodes de diagnostic et de pronostic pour troubles des poumons utilisant des profils d'expression de gènes de cellules épithéliales nasales |
EP2193211A4 (fr) | 2007-09-19 | 2010-12-08 | Univ Boston | Identification de nouvelles voies pour le développement de médicaments destinés à traiter une maladie des poumons |
US9495515B1 (en) | 2009-12-09 | 2016-11-15 | Veracyte, Inc. | Algorithms for disease diagnostics |
EP3626308A1 (fr) | 2013-03-14 | 2020-03-25 | Veracyte, Inc. | Procédés d'évaluation de l'état d'une maladie pulmonaire obstructive chronique (copd) |
US11976329B2 (en) | 2013-03-15 | 2024-05-07 | Veracyte, Inc. | Methods and systems for detecting usual interstitial pneumonia |
CN114606309A (zh) | 2014-11-05 | 2022-06-10 | 威拉赛特公司 | 使用机器学习和高维转录数据的诊断系统和方法 |
US10927417B2 (en) | 2016-07-08 | 2021-02-23 | Trustees Of Boston University | Gene expression-based biomarker for the detection and monitoring of bronchial premalignant lesions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1996039419A1 (fr) * | 1995-06-06 | 1996-12-12 | Human Genome Sciences, Inc. | Genes et proteines specifiques du colon |
US5939265A (en) * | 1996-11-05 | 1999-08-17 | Abbott Laboratories | Reagents and methods useful for detecting diseases of the lung |
EP0972056A1 (fr) * | 1997-01-31 | 2000-01-19 | Abbott Laboratories | Reactifs et procedes utiles pour detecter des maladies du poumon |
US6203979B1 (en) * | 1998-01-16 | 2001-03-20 | Incyte Pharmaceuticals, Inc. | Human protease molecules |
WO2000000610A2 (fr) * | 1998-06-26 | 2000-01-06 | Incyte Pharmaceuticals, Inc. | Proteines contenant un peptide signal humain |
-
1999
- 1999-05-12 WO PCT/US1999/010344 patent/WO1999060160A1/fr not_active Application Discontinuation
- 1999-05-12 EP EP99921894A patent/EP1082459A4/fr not_active Withdrawn
- 1999-05-12 CA CA002328138A patent/CA2328138A1/fr not_active Abandoned
- 1999-05-12 JP JP2000549766A patent/JP3688585B2/ja not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
WO1999060160A1 (fr) | 1999-11-25 |
EP1082459A4 (fr) | 2002-09-25 |
JP3688585B2 (ja) | 2005-08-31 |
JP2002515262A (ja) | 2002-05-28 |
EP1082459A1 (fr) | 2001-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2328138A1 (fr) | Technique de diagnostic, de suivi et de stadification du cancer du poumon | |
EP1080227B1 (fr) | Procédé de diagnostic, de surveillance et de détermination du stade du cancer du colon | |
EP2430193B1 (fr) | Marqueurs de détection de cancers gastriques | |
CN114250299A (zh) | 用于膀胱癌检测的尿标记物 | |
CA2341142A1 (fr) | Nouveau procede de diagnostic, de surveillance, de classification par stades, d'imagerie et de traitement de divers cancers | |
US20060035292A1 (en) | Differential diagnosis of cancer and other conditions based on expression of p63 | |
US6228596B1 (en) | Method of detecting and monitoring endometrial and uterine cancers | |
EP1270745A2 (fr) | Thymosin B15 comme marqueur dans le diagnostic et prognostic de cancer | |
JP3524061B2 (ja) | 肺がんを診断し、モニターし、病期決定し、画像化し、そして処置する新規な方法 | |
JP3677210B2 (ja) | 前立腺がんを診断し、モニターし、そして病期決定する新規な方法 | |
JP2002525031A (ja) | 大腸癌の診断、監視、病期決定、画像処理及び治療の新規方法 | |
US7713693B1 (en) | Human cancer cell specific gene transcript | |
US6949339B1 (en) | Method of diagnosing, monitoring, and staging colon cancer | |
US7160679B1 (en) | Method of diagnosing, monitoring, and staging lung cancer | |
US6861215B1 (en) | Method of diagnosing, monitoring, and staging prostate cancer | |
JP2002526760A (ja) | 消化器癌を診断、監視、病期分類、イメージング及び治療する新規な方法 | |
JP2002526055A (ja) | 婦人科癌及び精巣癌を診断、監視、病期分類、イメージング及び治療する方法 | |
US6379893B1 (en) | Evaluation of adenocarcinoma of the prostate and breast using anti-dystroglycan antibodies | |
EP1621639A2 (fr) | Nouveau procédé de diagnostic, de surveillance et de stadification du cancer de la prostate | |
AU2015255158A1 (en) | Urine markers for detection of bladder cancer | |
KR20230119346A (ko) | 흑색종 치료 내성 예측용 trim51 바이오마커 및 이의 용도 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
EEER | Examination request | ||
FZDE | Dead |